REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Proavisol S.A.S. (Colombia)

Main Activities: Poultry and Egg Production
Full name: Proavisol S.A.S. Profile Updated: December 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Proavisol S.A.S. is based in Colombia. The head office is in Bucaramanga. It operates in the Poultry and Egg Production industry. The company was established on September 27, 2016. It currently has a total number of 8 (2024) employees. The company’s latest financial report indicates a net sales revenue increase of 0.38% in 2023. There was a total growth of 2.65% in Proavisol S.A.S.’s total assets over the same period. In 2023, Proavisol S.A.S.’s net profit margin decreased by 5.39%.

Headquarters
Calle 63 D 3207 Local 7
Bucaramanga; Santander;

Contact Details: Purchase the Proavisol S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Proavisol S.A.S. report to view the information.
Outstanding Shares:
Purchase the Proavisol S.A.S. report to view the information.
Incorporation Date:
September 27, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Proavisol S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
0.38%▲
Total operating revenue
2.54%▲
Operating profit (EBIT)
-54.49%▼
Net Profit (Loss) for the Period
-37.37%▼
Total assets
2.65%▲
Total equity
12.1%▲
Operating Profit Margin (ROS)
-17.11%▼
Net Profit Margin
-5.39%▼
Return on Equity (ROE)
-8.53%▼
Debt to Equity Ratio
-23.15%▼
Quick Ratio
0%
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo